Lot of excess chatter & one word responses today, may have missed discussion of this... NP mentioned in the interview that both the FDA and MHRA are requesting interim data.
No penalty should be incurred as the trial isn't being stopped by CytoDyn, correct? The regulators get basically a free look and decide how things look to them.